Status:
NOT_YET_RECRUITING
PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised.
Lead Sponsor:
Kirby Institute
Conditions:
Invasive Fungal Infections
Invasive Bacterial Infection
Eligibility:
All Genders
18+ years
Brief Summary
We seek to characterise the burden and outcomes of and understand the current experience of people who inject drugs admitted to hospital with invasive injecting-related infections, in order to impleme...
Detailed Description
This study will be conducted as a prospective, observational cohort study of adults admitted with invasive bacterial and fungal infectious diseases. This study will be conducted at multiple hospitals ...
Eligibility Criteria
Inclusion
- Have voluntarily signed the informed consent form,
- 18 years of age or older,
- Injected drugs within the last 6 months,
- Admitted to hospital with invasive bacterial or fungal infection, a. Examples of invasive infection include: bloodstream infection, bone and joint infection (osteomyelitis, septic arthritis, discitis), central nervous system infection (epidural abscess, meningitis), deep abscess (i.e., brain, liver, muscle, spleen), endovascular infection (infective endocarditis, septic thrombophlebitis, mycotic aneurysm, septic embolism), skin or soft tissue infection (necrotising fasciitis, myositis),
Exclusion
- 1\) Is unable or unwilling to provide informed consent or abide by the requirements of the study.
Key Trial Info
Start Date :
March 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2029
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06220370
Start Date
March 1 2024
End Date
March 1 2029
Last Update
February 20 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.